BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31233285)

  • 1. Association of Sjögren's Syndrome With Reduced Lifetime Sex Hormone Exposure: A Case-Control Study.
    McCoy SS; Sampene E; Baer AN
    Arthritis Care Res (Hoboken); 2020 Sep; 72(9):1315-1322. PubMed ID: 31233285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Tobacco Smoking on The Clinical, Histopathological, and Serological Manifestations of Sjögren's Syndrome.
    Stone DU; Fife D; Brown M; Earley KE; Radfar L; Kaufman CE; Lewis DM; Rhodus NL; Segal BM; Wallace DJ; Weisman MH; Venuturupalli S; Brennan MT; Lessard CJ; Montgomery CG; Scofield RH; Sivils KL; Rasmussen A
    PLoS One; 2017; 12(2):e0170249. PubMed ID: 28166540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the hormone levels in patients with Sjogren's syndrome and healthy controls.
    Taiym S; Haghighat N; Al-Hashimi I
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):579-83. PubMed ID: 15153869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary Sjögren's syndrome as a systemic disease: a study of participants enrolled in an international Sjögren's syndrome registry.
    Malladi AS; Sack KE; Shiboski SC; Shiboski CH; Baer AN; Banushree R; Dong Y; Helin P; Kirkham BW; Li M; Sugai S; Umehara H; Vivino FB; Vollenweider CF; Zhang W; Zhao Y; Greenspan JS; Daniels TE; Criswell LA
    Arthritis Care Res (Hoboken); 2012 Jun; 64(6):911-8. PubMed ID: 22238244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance and Implications of Patient-reported Xerostomia in Sjögren's Syndrome: Findings From the National Institutes of Health Cohort.
    Billings M; Dye BA; Iafolla T; Baer AN; Grisius M; Alevizos I
    EBioMedicine; 2016 Oct; 12():270-279. PubMed ID: 27639822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural History and Predictors of Progression to Sjögren's Syndrome Among Participants of the Sjögren's International Collaborative Clinical Alliance Registry.
    Shiboski CH; Baer AN; Shiboski SC; Lam M; Challacombe S; Lanfranchi HE; Schiødt M; Shirlaw P; Srinivasan M; Umehara H; Vivino FB; Akpek E; Bunya V; Vollenweider CF; Greenspan JS; Daniels TE; Criswell LA;
    Arthritis Care Res (Hoboken); 2018 Feb; 70(2):284-294. PubMed ID: 28437595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of novel autoantibodies in Sjogren's syndrome utilizing Sera from the Sjogren's international collaborative clinical alliance cohort.
    Suresh L; Malyavantham K; Shen L; Ambrus JL
    BMC Ophthalmol; 2015 Apr; 15():38. PubMed ID: 25881294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The SSB-positive/SSA-negative antibody profile is not associated with key phenotypic features of Sjögren's syndrome.
    Baer AN; McAdams DeMarco M; Shiboski SC; Lam MY; Challacombe S; Daniels TE; Dong Y; Greenspan JS; Kirkham BW; Lanfranchi HE; Schiødt M; Srinivasan M; Umehara H; Vivino FB; Vollenweider CF; Zhao Y; Criswell LA; Shiboski CH;
    Ann Rheum Dis; 2015 Aug; 74(8):1557-61. PubMed ID: 25735642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low serum levels of sex steroids are associated with disease characteristics in primary Sjogren's syndrome; supplementation with dehydroepiandrosterone restores the concentrations.
    Forsblad-d'Elia H; Carlsten H; Labrie F; Konttinen YT; Ohlsson C
    J Clin Endocrinol Metab; 2009 Jun; 94(6):2044-51. PubMed ID: 19318446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Ratio of Blood T Follicular Regulatory Cells to T Follicular Helper Cells Marks Ectopic Lymphoid Structure Formation While Activated Follicular Helper T Cells Indicate Disease Activity in Primary Sjögren's Syndrome.
    Fonseca VR; Romão VC; Agua-Doce A; Santos M; López-Presa D; Ferreira AC; Fonseca JE; Graca L
    Arthritis Rheumatol; 2018 May; 70(5):774-784. PubMed ID: 29361207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological and hematological characteristics of Sjogren's syndrome and dry eye syndrome patients using a novel immune serology technique.
    Ben-Eli H; Solomon A; Aframian DJ; Ben-Chetrit E; Mevorach D; Kleinstern G; Waterboer T; Willhauck-Fleckenstein M; Pawlita M; Paltiel O
    PLoS One; 2020; 15(12):e0244712. PubMed ID: 33382786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lifelong estradiol exposure and risk of depressive symptoms during the transition to menopause and postmenopause.
    Marsh WK; Bromberger JT; Crawford SL; Leung K; Kravitz HM; Randolph JF; Joffe H; Soares CN
    Menopause; 2017 Dec; 24(12):1351-1359. PubMed ID: 28719421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome?
    Manthorpe R; Benoni C; Jacobsson L; Kirtava Z; Larsson A; Liedholm R; Nyhagen C; Tabery H; Theander E
    Ann Rheum Dis; 2000 Jan; 59(1):54-60. PubMed ID: 10627428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Anticentromere Antibodies With More Severe Exocrine Glandular Dysfunction in Sjögren's Syndrome: Analysis of the Sjögren's International Collaborative Clinical Alliance Cohort.
    Baer AN; Medrano L; McAdams-DeMarco M; Gniadek TJ
    Arthritis Care Res (Hoboken); 2016 Oct; 68(10):1554-9. PubMed ID: 26867144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sicca/Sjögren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International ImmunoCancer Registry (ICIR).
    Ramos-Casals M; Maria A; Suárez-Almazor ME; Lambotte O; Fisher BA; Hernández-Molina G; Guilpain P; Pundole X; Flores-Chávez A; Baldini C; Bingham Iii CO; Brito-Zerón P; Gottenberg JE; Kostine M; Radstake TRD; Schaeverbeke T; Schulze-Koops H; Calabrese L; Khamashta MA; Mariette X;
    Clin Exp Rheumatol; 2019; 37 Suppl 118(3):114-122. PubMed ID: 31464670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of interleukin-7 in labial salivary glands of patients with primary Sjögren's syndrome correlates with increased inflammation.
    Bikker A; van Woerkom JM; Kruize AA; Wenting-van Wijk M; de Jager W; Bijlsma JW; Lafeber FP; van Roon JA
    Arthritis Rheum; 2010 Apr; 62(4):969-77. PubMed ID: 20131250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The EULAR Sjogren's syndrome patient reported index as an independent determinant of health-related quality of life in primary Sjogren's syndrome patients: in comparison with non-Sjogren's sicca patients.
    Cho HJ; Yoo JJ; Yun CY; Kang EH; Lee HJ; Hyon JY; Song YW; Lee YJ
    Rheumatology (Oxford); 2013 Dec; 52(12):2208-17. PubMed ID: 24023247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex hormones, body mass index, and related comorbidities associated with developing Sjögren's disease: a nested case-control study.
    McCoy SS; Hetzel S; VanWormer JJ; Bartels CM
    Clin Rheumatol; 2022 Oct; 41(10):3065-3074. PubMed ID: 35701626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
    Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
    Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality and causes of death in primary Sjögren's syndrome: a prospective cohort study.
    Theander E; Manthorpe R; Jacobsson LT
    Arthritis Rheum; 2004 Apr; 50(4):1262-9. PubMed ID: 15077310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.